Royce & Associates’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
SBH
Royce & Associates's NGVT Position: Q2 2026 in Review
Royce & Associates increased its Ingevity (NGVT) stake by 6.4% in Q2 2026, buying an estimated $4.1M and bringing the position to 940,417 shares worth $70.2M. The position accounts for 0.57% of the portfolio, ranked #24.
Royce & Associates first reported a position in NGVT in Q1 2017 and has held it in 24 quarters since. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Royce & Associates held 940,417 shares of Ingevity worth $70.2M as of Q2 2026.
- Royce & Associates bought 56,890 Ingevity shares in Q2 2026, an estimated $4.1M.
- Ingevity made up 0.57% of Royce & Associates's portfolio in Q2 2026, its #24 holding.
- Royce & Associates first reported a position in Ingevity in Q1 2017 and has held it in 24 quarters since.
- 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.